Artha Sootra - Company Dashboard

Governance Classic Home

Rubicon Research LtdPharmaceuticalsINE506V01022Consolidated₹1716.55+0.25 (+0.01%)

Valuation

Market Cap₹28.39K Cr

TTM PE96.78x

Forward PE90.36x

PEG2.38

Book Value₹77.93

P/B22.03x

TTM EPS₹17.74

Fwd EPS₹19.00

TTM Revenue₹1.94K Cr

TTM PAT₹288.22 Cr

TTM EBITDA₹450.25 Cr

TTM EBIT₹399.42 Cr

Last Qtr PAT₹84.78 Cr

Last Qtr EBITDA₹129.12 Cr

Last Qtr EBIT₹113.98 Cr

Profitability

ROE22.36%

ROCE25.77%

TTM NPM14.89%

TTM EBITDA %23.26%

Curr OPM15.70%

Last OPM14.87%

Curr NPM—

Last NPM—

Curr EPS₹5.13

Last EPS₹4.66

Balance sheet

Equity₹16.51 Cr

Reserve₹1.27K Cr

Total Debt₹311.01 Cr

D/E0.24x

Interest %10.96%

Curr Interest₹9.29 Cr

Price / range

Close₹1716.80

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-0.07%

1W+9.68%

1M+5.04%

3M+13.10%

6M+75.95%

1Y+164.10%

2Y—

3Y—

5Y—

Diwali+153.05%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	427.73	389.88	301.71	336.47	1,306.08
Other Income	2.41	3.58	4.30	1.51	10.83
Total Income	430.14	393.46	306.01	337.98	1,316.91
Interest	6.01	5.40	7.51	9.21	30.96
Expenditure	-319.48	-299.27	-256.48	-276.35	-1,064.14
PBDT	0	0	0	0	0
EBITDA	124.83	106.18	62.25	79.11	310.65
Depreciation	-10.57	-10.17	-9.51	-9.78	-37.75
EBIT	114.26	96.01	52.74	69.33	272.90
PBT	110.66	94.19	49.53	61.63	252.78
Tax	-28.21	-24.17	-12.35	-15.82	-64.61
Equity	16.54	16.51	0	15.44	16.51
OPM	25.73	23.94	16.42	18.23	19.19
Net Profit	82.45	70.02	37.18	45.81	188.17
NPM	19.17	17.80	12.32	13.55	14.29
EPS	4.99	4.25	2.28	2.97	11.83

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	1,306.08
Other Income	10.83
Total Income	1,316.91
Expenditure	-1,064.14
Interest	-30.96
PBDT	0
EBITDA	310.65
Depreciation	-37.75
EBIT	272.90
PBT	252.78
Tax	-64.61
Equity	16.51
OPM (%)	19.19
Net Profit	188.17
NPM (%)	14.29
EPS (Rs)	11.83
CEPS	11.67

Metric	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	534.34	513.92	475.53	412.02	1,753.96
Other Income	5.68	2.61	3.79	0.70	7.73
Total Income	540.02	516.53	479.32	412.72	1,761.68
Interest	9.29	10.36	9.77	11.42	42.17
Expenditure	-429.65	-417.84	-388.73	-341.01	-1,441.15
PBDT	0	0	0	0	0
EBITDA	129.12	118.71	108.12	94.30	400.24
Depreciation	-15.14	-12.27	-11.55	-11.87	-45.26
EBIT	113.98	106.44	96.57	82.43	354.98
PBT	110.37	98.69	90.59	71.71	320.53
Tax	-25.59	-21.90	-17.79	-17.85	-73.80
Equity	16.54	16.51	0	15.44	16.51
OPM	20.44	19.11	18.90	17.37	18.19
Net Profit	84.78	76.79	72.80	53.85	246.74
NPM	15.70	14.87	15.19	13.05	14.01
EPS	5.13	4.66	4.46	3.49	15.52

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26
Revenue	1,753.96
Other Income	7.73
Total Income	1,761.68
Expenditure	-1,441.15
Interest	-42.17
PBDT	0
EBITDA	400.24
Depreciation	-45.26
EBIT	354.98
PBT	320.53
Tax	-73.80
Equity	16.51
OPM (%)	18.19
Net Profit	246.74
NPM (%)	14.01
EPS (Rs)	15.52
CEPS	15.31

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	1.5	07 Aug 2026

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split